Treatments & Interventions
Uramustine
substance
Cortisone
substance
Methoxsalen
substance
Methylprednisolone acetate
substance
Prednisolone acetate
substance
Prednisolone sodium phosphate
substance
Prednisolone tertiary butylacetate
substance
Interferon alfacon-1
substance
Dexamethasone acetate
substance
Methylprednisolone
substance
Prednisolone
substance
Cortisone acetate
substance
Dexamethasone
substance
Mechlorethamine
substance
Interferon gamma-1b
substance
Interferon alfa-2a
substance
Interferon alfa-2b
substance
Vinblastine
substance
Mechlorethamine hydrochloride
substance
Vinblastine sulphate
substance
Clinical Trials
Recent Trials
A Phase I Trial Anti-CC Chemokine Receptor 4 Chimeric Antigen Receptor T Cells (CCR4 CAR T Cells) for CCR4 Expressing T-cell Malignancies Including Peripheral T-cell Non-Hodgkin Lymphoma (PTCL) and Cutaneous T-cell Non-Hodgkin Lymphoma (CTCL)
Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers
Duvelisib and Nivolumab for the Treatment of Stage IIB-IVB Mycosis Fungoides and Sezary Syndrome
Anti-ICOS Monoclonal Antibody MEDI-570 in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma Follicular Variant or Angioimmunoblastic T-cell Lymphoma
Study of ONTAK (Denileukin Diftitox) in Cutaneous T-Cell Lymphoma (CTCL) Patients
Research Evidence
Peer-reviewed studies linked via MeSH term "Mycosis Fungoides" from the MEDLINE/PubMed database.
Research data from MEDLINE/PubMed
Signs & Symptoms
Based on Human Phenotype Ontology (HPO) disease-phenotype annotations.
Related Conditions
Quick Facts
- SNOMED CT
- 118618005
- UMLS CUI
- C0026948
- Fully Specified Name
- Mycosis fungoides (disorder)
- Specialists
- 0
- Diagnostic Biomarkers
- 0
- HPO Phenotypes
- 8
- Known Treatments
- 20
- Clinical Trials
- 8
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.